The behavior and diagnostic utility of procalcitonin and five other inflammatory molecules in critically ill patients with respiratory distress and suspected 2009 influenza a H1N1 infection

Clinics

Volumn 67, Issue 4, 2012, Pages 327-334

  Paiva, Mariana Benevides Santos ^a   Botoni, Fernando Antônio ^a   Teixeira, Antônio Lúcio ^a   de Miranda, Aline Silva ^a   de Oliveira, Clara Rodrigues Alves ^a   Abrahão, Jamila de Oliveira ^a   Faria, Guilherme Marques ^a   Nobre, Vandack ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Biomarker; C reactive protein; Sensitivity; Severe respiratory distress syndrome; Specificity

Indexed keywords

EID: 84860184507     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(04)05     Document Type: Article

References (33)

1. Funk DJ, Siddiqui F, Wiebe K, Miller RR 3rd, Bautista E, Jimenez E, et al. Practical lessons from the first outbreaks: clinical presentation, obstacles, and management strategies for severe pandemic (pH1N1) 2009 influenza pneumonitis. Crit Care Med. 2010;38(4 Suppl):e30-37.
2. Webb SA, Pettila V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361(20):1925-34.
3. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautista E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361(7):680-9, http://dx.doi.org/10.1056/NEJMoa0904252.
4. Trifonov V, Khiabanian H, Rabadan R. Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus. N Engl J Med. 2009;361(2):115-9, http://dx.doi.org/10.1056/NEJMp0904572.
5. Secretaria de Vigilância em Saúde. Situação epidemiológica da Influenza Pandêmica (H1N1) 2009 no Mundo e no Brasil, até a Semana Epidemiológica 47 de 2009. Informe epidemiológico Influenza Pandêmica (H1N1) 2009. 2009;1(11):1-11.
6. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA. 2009;302(17):1872-9, http://dx.doi.org/10.1001/jama.2009.1496.
7. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009;361(20):1935-44, http://dx.doi.org/10.1056/NEJMoa0906695.
8. Dominguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA. 2009;302(17):1880-7, http://dx.doi.org/10.1001/jama.2009.1536.
9. Boggild AK, McGeer AJ. Laboratory diagnosis of 2009 H1N1 influenza A virus. Crit Care Med. 2010;38(4 Suppl):e38-42, http://dx.doi.org/10.1097/CCM.0b013e3181cd7bb2.
10. Dubos F, Moulin F, Gajdos V, De Suremain N, Biscardi S, Lebon P, et al. Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. J Pediatr. 2006;149(1):72-6.
11. Gendrel D, Bohuon C. Procalcitonin in pediatrics for differentiation of bacterial and viral infections. Intensive Care Med. 2000;26(Suppl 2):S178-81.
12. Ingram PR, Inglis T, Moxon D, Speers D. Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. Intensive Care Med. 2010;36(3):528-32, http://dx.doi.org/10.1007/s00134-009-1746-3.
13. Guervilly C, Coisel Y, Botelho-Nevers E, Dizier S, Castanier M, Lepaul-Ercole R, et al. Significance of high levels of procalcitonin in patients with influenza A (H1N1) pneumonia. J Infect. 2010;61(4):355-8, http://dx.doi.org/10.1016/j.jinf.2010.07.013.
14. Cunha BA, Syed U, Strollo S. Swine influenza (H1N1) pneumonia: elevated serum procalcitonin levels not due to superimposed bacterial pneumonia. Int J Antimicrob Agents. 2010;35(5):515-6, http://dx.doi.org/10.1016/j.ijantimicag.2010.01.005.
15. Cuquemelle E, Soulis F, Villers D, Roche-Campo F, Ara Somohano C, Fartoukh M, et al. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. Intensive Care Med. 2011;37(5):796-800, http://dx.doi.org/10.1007/s00134-011-2189-1.
16. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature. 2009;460(7258):1021-5.
17. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med. 2003;138(1):40-4.
18. Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med. 1981;9(8):591-7, http://dx.doi.org/10.1097/00003246-198108000-00008.
19. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on sepsis-related problems of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26(11):1793-1800, http://dx.doi.org/10.1097/00003246-199811000-00016.
20. CDC Protocol of Realtime RTPCR for Influenza A (H1N1). 2009. http://www.who.int/csr/resources/publications/swineflu/CDCRealtimeRTPCR_SwineH1Assay-2009_20090430.pdf. Accessed March 18th, 2011.
21. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31, http://dx.doi.org/10.1186/cc5713.
22. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;164(3):396-402.
23. Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med. 2000;28(4):977-83, http://dx.doi.org/10.1097/00003246-200004000-00011.
24. Brunkhorst FM, Eberhard OK, Brunkhorst R. Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med. 1999;27(10):2172-6, http://dx.doi.org/10.1097/00003246-199910000-00016.
25. Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med. 1999;27(3):498-504, http://dx.doi.org/10.1097/00003246-199903000-00024.
26. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med. 2006;34(10):2596-602, http://dx.doi.org/10.1097/01.CCM.0000239116.01855.61.
27. Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care. 1999;3(1):45-50, http://dx.doi.org/10.1186/cc306.
28. Piacentini E, Sanchez B, Arauzo V, Calbo E, Cuchi E, Nava JM. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study. J Crit Care. 2011;26(2):201-5.
29. Takano T, Tajiri H, Kashiwagi Y, Kimura S, Kawashima H. Cytokine and chemokine response in children with the 2009 pandemic influenza A (H1N1) virus infection. Eur J Clin Microbiol Infect Dis. 2011;30(1):117-20, http://dx.doi.org/10.1007/s10096-010-1041-9.
30. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramirez P, et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care. 2009;13(6):R201, http://dx.doi.org/10.1186/cc8208.
31. Charles PE, Tinel C, Barbar S, Aho S, Prin S, Doise JM, et al. Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome. Crit Care. 2009;13(2):R38, http://dx.doi.org/10.1186/cc7751.
32. Ho KM, Lee KY, Dobb GJ, Webb SA. C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study. Intensive Care Med. 2008;34(3):481-7, http://dx.doi.org/10.1007/s00134-007-0928-0.
33. Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med. 2008;121(3):219-25, http://dx.doi.org/10.1016/j.amjmed.2007.10.033.